| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, CEO, Chairman | EVP and Chief Strategy Officer
1 company
Lance Alstodt last filed a Form 4 in October 2025, as President, CEO, Chairman at BRTX. From August 2019 to October 2025, the filings on record show 33 open-market purchases and 0 sales. Lance Alstodt's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Lance Alstodt's trades have earned a middling insider score of 55/100 across 29 rated trades. Over a 12-month horizon, 37.9% of those trades were profitable, with an average 12-month return of -10.2%.
At the last filing, the largest reported position was 187,497 shares of BRTX. Net of sales, the BRTX filings show accumulation of 83,552 shares.
Shares as reported in the last Form 4 for each company; the most recent is from October 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 200 | $4.60 | $920.00 | +0.1% | -29.1% | +19.3% | |
| May 26, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 2,700 | $3.52 | $9,494.01 | +1.5% | -4.9% | +62.7% | |
| May 2, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 400 | $3.95 | $1,578.80 | +0.2% | -22.9% | +4.3% | |
| Jan 24, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 1,470 | $3.40 | $4,998.00 | +0.9% | +16.5% | -10.4% | |
| Jan 5, 2022 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 2,000 | $3.85 | $7,700.00 | +1.3% | +47.4% | -28.2% | |
| Dec 1, 2021 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 799 | $5.50 | $4,394.50 | +0.5% | -2.1% | -42.5% | |
| Nov 23, 2021 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 2,500 | $6.00 | $15,000.00 | +1.6% | -15.3% | -56.7% | |
| Nov 22, 2021 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 396 | $6.31 | $2,498.76 | +0.3% | -18.2% | -52.9% | |
| Nov 16, 2021 | BRTX Biorestorative Therapies, Inc. | President, CEO, Chairman | Buy | 4,500 | $6.71 | $30,201.00 | +3.0% | -37.9% | -55.6% | |
| Sep 9, 2019 | BRTX Biorestorative Therapies, Inc. | EVP and Chief Strategy Officer | Buy | 20,000 | $0.26 | $5,220.00 | +66.7% | - | - |